Consistent with beneficial results of immunization-based treatment of transgenic mouse models, therefore, immunological modulation of misfolded SOD1 in extracellular fluids such as CSF would be a promising strategy to delay onset and/or relieve symptoms of ALS. Here, SOD1 is linked to amyotrophic lateral sclerosis.